Co-codamol (Codeine phosphate/paracetamol) vs Galcanezumab
Co-codamol (Codeine phosphate/paracetamol) was dispensed 410,793.7× as often as Galcanezumab in March 2026 — 1,232,381 items versus 3 in England.
1,232,381items
Co-codamol (Codeine phosphate/paracetamol) · March 2026
NHSBSA Prescription Cost Analysis
3items
Galcanezumab · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Co-codamol (Codeine phosphate/paracetamol) versus Galcanezumab: national items dispensed by month
▬ Co-codamol (Codeine phosphate/paracetamol) · ╌ Galcanezumab
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Co-codamol (Codeine phosphate/paracetamol) | Galcanezumab |
|---|---|---|
| Items, March 2026 | 1,232,381 | 3 |
| Items, last 12 months | 14,910,786 | 28 |
| Net ingredient cost, March 2026 | £7,059,673 | £1,350 |
See the full profile for Co-codamol (Codeine phosphate/paracetamol) or Galcanezumab.